Hepatocellular carcinoma (HCC) is a highly aggressive and lethal malignancy with limited treatment options. Despite significant advancements in drug development for HCC, the high cost of therapy remains a major challenge for patients and healthcare systems globally. Balancing efficacy and cost in HCC drug treatment is crucial to ensure that patients receive optimal therapy while also managing...
0 Commentarios
0 Acciones
1522 Views
0 Vista previa